Literature DB >> 19005416

Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury.

Karen Keslar1, E Rene Rodriguez, Carmela D Tan, Randall C Starling, Peter S Heeger.   

Abstract

Complement activation contributes to antibody-mediated allograft rejection, but increasing evidence also implicates complement proteins produced locally within the graft, in part by infiltrating mononuclear cells, as important mediators of tissue injury. To test this concept in transplant recipients, we evaluated complement, complement regulator, and T cell/proinflammatory marker gene expression by quantitative real-time polymerase chain reaction in 71 archived heart transplant biopsies and correlated the results with the histologic grade of rejection. Significantly more transcripts encoding alternative pathway components factor B, C3 and properdin, and C3a receptor and C5a receptor were detected in grade 3 versus grade 0 or 1 biopsies. The grade 3 rejections also contained significantly higher amounts of CD3, interferon gamma, perforin, and granzyme B genes. In addition to providing supportive evidence for a pathogenic role of graft-derived complement in human heart transplant injury, these correlations suggest that molecular profiling of complement gene expression could be useful in the diagnosis of human allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005416      PMCID: PMC2646139          DOI: 10.1097/TP.0b013e3181889831

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

Authors:  Susan Stewart; Gayle L Winters; Michael C Fishbein; Henry D Tazelaar; Jon Kobashigawa; Jacki Abrams; Claus B Andersen; Annalisa Angelini; Gerald J Berry; Margaret M Burke; Anthony J Demetris; Elizabeth Hammond; Silviu Itescu; Charles C Marboe; Bruce McManus; Elaine F Reed; Nancy L Reinsmoen; E Rene Rodriguez; Alan G Rose; Marlene Rose; Nicole Suciu-Focia; Adriana Zeevi; Margaret E Billingham
Journal:  J Heart Lung Transplant       Date:  2005-06-20       Impact factor: 10.247

2.  TNF-alpha regulation of C3 gene expression and protein biosynthesis in rat glomerular endothelial cells.

Authors:  N S Sheerin; W Zhou; S Adler; S H Sacks
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

3.  Expression and function of C5a receptor in mouse microvascular endothelial cells.

Authors:  Ines J Laudes; Jeffrey C Chu; Markus Huber-Lang; Ren-Feng Guo; Niels C Riedemann; J Vidya Sarma; Fakhri Mahdi; Hedwig S Murphy; Cecilia Speyer; Kristina T Lu; John D Lambris; Firas S Zetoune; Peter A Ward
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

4.  Local synthesis of complement component C3 regulates acute renal transplant rejection.

Authors:  Julian R Pratt; Shamim A Basheer; Steven H Sacks
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

5.  Synthesis of factor D by gastric cancer-derived cell lines.

Authors:  Etsuko Kitano; Hajime Kitamura
Journal:  Int Immunopharmacol       Date:  2002-05       Impact factor: 4.932

6.  Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms.

Authors:  R S Selvan; H B Kapadia; J L Platt
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

7.  Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.

Authors:  Peter N Lalli; Michael G Strainic; Feng Lin; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

8.  Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

Authors:  Tao Lin; Wuding Zhou; Conrad A Farrar; Roseanna E G Hargreaves; Neil S Sheerin; Steven H Sacks
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

9.  Decay-accelerating factor modulates induction of T cell immunity.

Authors:  Peter S Heeger; Peter N Lalli; Feng Lin; Anna Valujskikh; Jinbo Liu; Nasima Muqim; Yuanyuan Xu; M Edward Medof
Journal:  J Exp Med       Date:  2005-05-09       Impact factor: 14.307

10.  Local extravascular pool of C3 is a determinant of postischemic acute renal failure.

Authors:  Conrad A Farrar; Wuding Zhou; Tao Lin; Steven H Sacks
Journal:  FASEB J       Date:  2006-02       Impact factor: 5.191

View more
  17 in total

Review 1.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Native properdin binds to Chlamydia pneumoniae and promotes complement activation.

Authors:  Claudio Cortes; V P Ferreira; Michael K Pangburn
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

Review 3.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

Review 4.  Complement regulation of T cell immunity.

Authors:  Wing-hong Kwan; William van der Touw; Peter S Heeger
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 5.  Complement as a multifaceted modulator of kidney transplant injury.

Authors:  Paolo Cravedi; Peter S Heeger
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 6.  Innate immunity and cardiac allograft rejection.

Authors:  Timothy M Millington; Joren C Madsen
Journal:  Kidney Int Suppl       Date:  2010-12       Impact factor: 10.545

Review 7.  Complement regulation of T-cell alloimmunity.

Authors:  Hugo Raedler; Peter S Heeger
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

Review 8.  Evolving paradigms that determine the fate of an allograft.

Authors:  J S Bromberg; P S Heeger; X C Li
Journal:  Am J Transplant       Date:  2010-02-25       Impact factor: 8.086

9.  Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.

Authors:  R C Starling; J Stehlik; D A Baran; B Armstrong; J R Stone; D Ikle; Y Morrison; N D Bridges; P Putheti; T B Strom; M Bhasin; I Guleria; A Chandraker; M Sayegh; K P Daly; D M Briscoe; P S Heeger
Journal:  Am J Transplant       Date:  2015-08-10       Impact factor: 8.086

Review 10.  The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

Authors:  Stefan O Ciurea; Kai Cao; Marcelo Fernandez-Vina; Piyanuch Kongtim; Monzr Al Malki; Ephraim Fuchs; Leo Luznik; Xiao-Jun Huang; Fabio Ciceri; Franco Locatelli; Franco Aversa; Luca Castagna; Andrea Bacigalupo; Massimo Martelli; Didier Blaise; Rupert Handgretinger; Denis-Claude Roy; Paul O'Donnell; Asad Bashey; Hillard M Lazarus; Karen Ballen; Bipin N Savani; Mohamad Mohty; Arnon Nagler
Journal:  Bone Marrow Transplant       Date:  2018-01-15       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.